$BAC, $GOOGL, $ILMN, $NVS
The industry focused on extending humans’ lives beyond the normal lifespan could be worth at least $600-B in Y 2025 and the average lifespan could hit 100 years before we know it, according to a new report.
A study performed by 2 analysts at Bank of America Merrill Lynch (NYSE:BAC) found that there is a race to help people live longer is moving at Top speed.
There are several pieces to the puzzle, including genomics, artificial intelligence, food, and medicine.
Companies such as Illumina (NYSE:ILMN), Alphabet (NASDAQ:GOOGL), and Novartis (NYSE:NVS) are working to solve the mystery of how to use science to increase lifespan.
“Medical knowledge will double every 73 days by 2020 Vs every 3.5 year in 2010, and genomic sequencing costs have fallen 99.999% since 2003,” analysts Felix Tran and Haim Israel wrote in their report. “This has enabled a new frontier in precision medicine to further extend life expectancy, heralding a ‘techmanity’ (technology meets humanity) revolution.”
The technology could soon be developed to push the average lifespan over 100, analysts Tran and Israel found.
The average lifespan in the United States is just under 79 years.
According to a report last month, people who live to 105 anni have a good chance to continue living after that because of how cells work.
Another report last fall claimed that the 1st human to live to 1,000 years might already be alive.
Wild, my goal for the past 20 years is to live to be 200 anni, as I learn more I will adjust it Northward.
Eat healthy, Be healthy, Live lively
Latest posts by Paul Ebeling (see all)
- The Street’s Key Stock Analysts Research Reports - August 22, 2019
- Asia: Gold, USD, Crude Oil, Stocks & Commodities - August 22, 2019
- Ford V Ferrari is the Most Important Film for Fox’s Future With Disney - August 21, 2019